AZT selectively targets HIV reverse transcriptase over human DNA polymerase.
the verdict
SUPPORTED
the evidence backs this
confidence 93/100
Scientific literature confirms that AZT and related nucleoside analogues selectively inhibit HIV reverse transcriptase to suppress viral replication while minimizing impact on normal cellular functions.
Evidence for · 4
HIV-1 Antiretroviral Drug Therapy
2012 · cited by 853
Paper 0 discusses nucleoside-analog reverse transcriptase inhibitors like AZT that specifically target and suppress HIV replication.
See more details
More for · 3
HIV-1 Reverse Transcription
2012 · cited by 475
Paper 1 outlines how reverse transcriptase is a virally encoded enzyme utilized by retroviruses, forming the basis for selective drug targeting.
Selective Excision of AZTMP by Drug-Resistant Human Immunodeficiency Virus Reverse Transcriptase
2001 · cited by 258
Paper 6 details the structural and biochemical mechanisms by which HIV reverse transcriptase interacts with AZT.
HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase
1993 · cited by 166
Paper 8 describes how specific reverse transcriptase inhibitors exhibit high selectivity against viral enzymes without inhibiting cellular DNA polymerases.